Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
As per available reports about 32 relevant journals, 12 Conferences, 31 workshops are presently dedicated exclusively to Cross protective immunity and about 2,080 articles are being published on Cross protective immunity.
Cross-protective immunity applies to the reaction between two different species as opposed to the self-reactivity. In chemistry it signifies a reaction between two different molecules. At the same time each of these molecules is able to react with the identical molecule, or as it is conventionally described, to react with itself. In immunology, the cross-reactivity has a more narrow meaning of the reaction between an antibody and an antigen that differs from the immunogen. It is sometimes withal referred to as crossimmunity or cross-protective immunity, albeit cross-reactivity does not obligatorily infer cross-aegis. A few examples of cross-reactivity have been attested in humans, one of which involves influenza virus-categorical CD8+ T cell and hepatitis C virus antigens.
An adaptive immune replication is categorical to the antigen that stimulated it (called the immunogen). However, many naturally occurring 'antigens' are a mixture of macromolecules (e.g. from pathogens, toxins, proteins, pollen) comprising several epitopes. Contact with an intricate antigen such as a virus will stimulate multiple immune replications to the virus' different macromolecules as well as the individual epitopes of each macromolecule. For example, the tetanus toxin is a single protein macromolecular antigen but will stimulate many immune replications due to the tertiary structure of the protein yielding many different epitopes. The toxin that engenders the immune replication will have an epitope on it that stimulates the replication. Denaturing the protein may 'disarm' its function but sanction the immune system to have an immune replication thus engendering an immunity without harming the patient.
Cross-reactivity is additionally a commonly evaluated parameter for the validation of immune and protein binding predicated assays such as ELISA and RIA. In this case it is mundanely quantified by comparing the assays replication to a range of homogeneous analytes and expressed as a percentage. In practice, calibration curves are engendered utilizing fine-tuned concentration ranges for a cull of cognate compounds and the midpoints (IC50) of the calibration curves are calculated and compared. The figure then provides an estimate of the replication of the assay to possible interfering compounds relative to the target analyte.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
The global market for Cross protective immunity reached $6.5 billion in 2013. This market should grow to $10 billion in 2014 and about $21.9 billion in 2018, a compound annual growth rate (CAGR) of 27.3%.
• Vaccination Clinics - Humane Society of Broward County
• Vaccine Clinics - Connecticut Humane Society
• Vaccine Clinics | Wisconsin Humane Society
• Australian Vaccinologists society
• The american Vaccines and vaccination society.
• US Immunology society.
• World immunization Association
• American Immunologists association.
• North California medical society
• RMS MS Contin
• Endo Pharmaceuticals
• Benforce M
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising